Onconova Therapeutics Quarterly Earnings. Should You Buy?
Onconova Therapeutics Quarterly Earnings. Should You Buy?: Onconova Therapeutics (NASDAQ: ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for patients with cancer, announces financial results for the twelve months ended December 31, 2020 and provides a business update. Highlights of the fourth quarter of 2020 and recent weeks include: ON 123300, Onconova’s proprietary multi-kinase inhibitor, received clearance from […]
Comments
Post a Comment